Natera, Inc. - Common Stock — Cash Flow (NASDAQ:NTRA) | MetaTrader

Open full chart

Financials

Overview Statement Statistics

Quarterly Annual

Cash from operating activities -182.51 M-335.24 M-431.5 M-246.96 M135.66 M215.3 M 211.02 M Cash from investing activities -331.46 M-205.19 M330.34 M168.5 M137.62 M-132.21 M -147.53 M Cash from financing activities 500.85 M576.19 M482.64 M254.46 M30.2 M47.46 M 50.67 M Free cash flow -182.51 M-335.24 M-431.5 M-246.96 M135.66 M215.3 M 211.02 M

News

Cathie Wood Bought $54 Million Worth Of SpaceX Stock Last Week

NTRA's Signatera Gains EU IVDR Certification for Multiple Cancers

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

NTRA & Aveta Partner to Advance MRD-Guided Trial in Head & Neck Cancer

Medical Services Name Tests For Colon Cancer. Natera Stock Hits A High.

Natera: All-Time Share Price High A Potential Caveat For Investors, Despite Promise

The Disinflation Trade Has A New Address: Genomics

NTRA's Signatera Secures PMDA Approval for MRD Testing in CRC in Japan

Natera (NTRA) Stock Jumps 10.7%: Will It Continue to Soar?

Biotech Medical Test Leader Hits Record High, Joins 15 Others New To Best Stock Lists

Natera Flashes A Buy Signal. Why Shares Just Leaped By Double Digits.

EXEL Down on Colorectal Cancer Study Data on Zanzalintinib